Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Transglutaminase-6 is an autoantigen in progressive multiple sclerosis and is upregulated in reactive astrocytes.

Cristofanilli M, Gratch D, Pagano B, McDermott K, Huang J, Jian J, Bates D, Sadiq SA.

Mult Scler. 2017 Nov;23(13):1707-1715. doi: 10.1177/1352458516684022. Epub 2016 Dec 22.

PMID:
28273770
2.

Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration.

van Strien ME, de Vries HE, Chrobok NL, Bol JGJM, Breve JJP, van der Pol SMP, Kooij G, van Buul JD, Karpuj M, Steinman L, Wilhelmus MM, Sestito C, Drukarch B, Van Dam AM.

Brain Behav Immun. 2015 Nov;50:141-154. doi: 10.1016/j.bbi.2015.06.023. Epub 2015 Jun 29.

PMID:
26133787
3.

Tissue transglutaminase in marmoset experimental multiple sclerosis: discrepancy between white and grey matter.

Espitia Pinzon N, Stroo E, 't Hart BA, Bol JG, Drukarch B, Bauer J, van Dam AM.

PLoS One. 2014 Jun 24;9(6):e100574. doi: 10.1371/journal.pone.0100574. eCollection 2014.

4.

Appearance of tissue transglutaminase in astrocytes in multiple sclerosis lesions: a role in cell adhesion and migration?

van Strien ME, Drukarch B, Bol JG, van der Valk P, van Horssen J, Gerritsen WH, Breve JJ, van Dam AM.

Brain Pathol. 2011 Jan;21(1):44-54. doi: 10.1111/j.1750-3639.2010.00428.x. Epub 2010 Aug 20.

PMID:
20731658
5.

Pathogenesis of autoimmune diseases: antibodies against transglutaminase, peptidylarginine deiminase and protein-bound citrulline in primary Sjögren's syndrome, multiple sclerosis and Alzheimer's disease.

Bodil Roth E, Theander E, Londos E, Sandberg-Wollheim M, Larsson A, Sjöberg K, Stenberg P.

Scand J Immunol. 2008 Jun;67(6):626-31. doi: 10.1111/j.1365-3083.2008.02115.x.

Supplemental Content

Loading ...
Support Center